Palm Beach Gardens, FL – (September 27, 2013) – BIOMET 3i, one of the world’s leading dental implant manufacturers, announced today that it made adjustments to its Executive Committee led by President Bart Doedens.
Effective October 7th, Mr. David Josza is returning to the organization as the Vice President of North American Sales. Mr. Josza has extensive dental experience having worked for more than 10 years in the industry, and is familiar with many dental implant professionals. His return to BIOMET 3i marks a strengthening of focus on the North American marketplace.
Mr. Lars Janson is assuming the role of Vice President of Global Marketing and Education. Throughout his long tenure at BIOMET 3i, Mr. Janson has been instrumental in many aspects of the company including EMEA & APAC commercial operations and leading the BIOMET 3i Institute for Implant and Reconstructive Dentistry.
“These adjustments to my Executive Committee are the key to a successful future,” says Doedens. “The breadth of expertise each of these individuals brings to the organization is essential to our continued innovation and growth.”
According to Doedens, these adjustments will enable the company to continue to focus on the success of its 3i T3® Implant, which is a contemporary hybrid implant with a new multi-surface topography designed to deliver aesthetic results through tissue preservation.
BIOMET 3i is also focused on the successfully performing BellaTek® Encode® Impression System, which eliminates impression copings and includes a healing abutment with embedded codes on the occlusal surface that provide the necessary information to design and mill the definitive abutment.
BIOMET 3i Announces Adjustments to its Executive Committee
siteground September 27, 20131 Mins read165 Views
Previous post Carestream Dental’s CS 8100 Digital Panoramic Imaging System Receives 2013 International Medical Design Excellence Award